glp-1 eating disorders obesity drugs and are not well understood yet : NPR GLP-1 RAs in Eating Disorders:

While often benign, persistent or severe cases may warrant closer evaluation

In parental (wild-type mtDNA) cells, 5FU drives significant increases in mitochondrial mass

Gastrointestinal Effects in Trial Data Gastrointestinal adverse events have appeared most often across the retatrutide trial program

Catecholamines suppress leptin release from in vitro differentiated subcutaneous human adipocytes in primary culture via beta1- and beta2-adrenergic receptors

For an older adult, a sarcopenic patient, an athlete, or anyone close to a functional threshold, absolute kg of skeletal muscle is what determines metabolic flexibility, fall risk, and long-term function

Liposomes as carriers of GHK-Cu tripeptide for cosmetic application